Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-10-03 Tax Withholding | 2024-10-07 9:24 pm | N/A N/A | OptimizeRx Corp | OPRX | Besch Doug Chief Product Officer | 976 | $7.83 | 13,521 (Direct) | View |
| 2024-10-03 Exercise | 2024-10-07 9:24 pm | N/A N/A | OptimizeRx Corp | OPRX | Besch Doug Chief Product Officer | 3,324 | $0 | 13,521 (Direct) | View |
| 2024-02-15 Option Award | 2024-04-24 10:18 am | N/A N/A | OptimizeRx Corp | OPRX | Besch Doug Chief Product Officer | 4,000 | $0 | 7,848 (Direct) | View |
| 2023-12-19 Option Award | 2024-02-21 6:25 pm | N/A 2026-12-19 | OptimizeRx Corp | OPRX | Besch Doug Chief Product Officer | 11,784 | $0 | 11,784 (Direct) | View |
| 2023-10-03 Tax Withholding | 2023-10-06 2:47 pm | N/A N/A | OptimizeRx Corp | OPRX | Besch Doug Chief Product Officer | 976 | $7.06 | 10,497 (Direct) | View |
| 2023-10-03 Exercise | 2023-10-06 2:47 pm | N/A N/A | OptimizeRx Corp | OPRX | Besch Doug Chief Product Officer | 3,324 | $0 | 10,497 (Direct) | View |
| 2022-10-03 Option Award | 2022-10-05 1:14 pm | N/A N/A | OptimizeRx Corp | OPRX | Besch Doug Chief Product Officer | 29,500 | $0 | 29,500 (Direct) | View |
Ownership | 2022-10-03 2:57 pm | N/A N/A | OptimizeRx Corp | OPRX | Besch Doug Chief Product Officer | 0 | $0 | 16,500 (Direct) | View |